Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP)
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Study will evaluate the safety and tolerability of once daily Biktarvy for 28 days for
prevention of HIV infection in HIV-1-seronegative adults after high-risk sexual contact.
(non-occupational post exposure prophylaxis - nPEP)